Sider

▼
fredag den 29. maj 2020

Kynurenine skal afprøves til behandling af ME patienter

›
Open Medicine Foundation finansierer et nyt placebo-kontrolleret studie, hvor ME patienter skal behandles med kynurenine: Kynurenine Cl...
mandag den 4. maj 2020

Serum fra ME patienter udviser antiviral aktivitet

›
Et nyt studie af Schreiner et al har vist, at serum fra ME patienter udviser antiviral aktivitet mod både DNA- og RNA-virus i en cellekultur...
torsdag den 5. marts 2020

ME - a failure of inducing exercise tolerance?

›
ME hypothesis from Karolinska Institutet and Karolinska University Hospital in Sweden (1): "ME - a failure of inducing disease toleranc...
tirsdag den 3. marts 2020

Det inflammatoriske respons og induktion af sygdomstolerance er dysreguleret hos ME patienter

›
Forskere fra Karolinska Instituttet og Karolinska Universitetshospital har beskrevet en ME hypotese (1): "ME - a failure of inducing ...
mandag den 2. marts 2020

Increased serum and urine 3-methylhistidine in ME patients

›
3-metylhistidine is a breakdown product of muscle contractile proteins. Serum or urine 3-methylhistidine is used as a biomarker of muscle pr...
onsdag den 19. februar 2020

Increased plasma N,N,N-trimethyl-L-alanyl-L-proline betaine in ME patients

›
N,N,N-trimethyl-L-alanyl-L-proline betaine (TMAP) is a plasma biomarker of reduced kidney function (1). Quote from ref 1: " TMAP was...
onsdag den 5. februar 2020

Proline, P5C and 4-hydroxyglutamate in ME

›
What do Pre-eclampsia The inborn error of metabolism: Primary Hyperoxaluria Type 3 Myalgic encephalomyelitis (ME) have in common? ...